Shazia K. Nakhoda, MD

Dr. Shazia Nakhoda
​​
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings

Assistant Professor, Department of Hematology/Oncology

Hematology-Lymphoma Program

Specialties

Treatment Focus

Malignant Hematology; Central Nervous System Lymphoma

Treatment Philosophy

Navigating a new cancer diagnosis can be challenging and overwhelming. I feel honored to be part of a team that provides patients and their families not only specialized oncologic care, but also the support and resources needed. The collaborative network of clinicians, nurses, and researchers at Fox Chase allows me to provide my patients individualized treatment options, novel therapies, and access to clinical trials. In addition, I strive to provide my patients and their families compassionate and comprehensive clinical care throughout each aspect of their journey.

Clinical Locations

Educational Background

  • Hematology & Oncology Fellowship Training, Temple University and Fox Chase Cancer Center, Philadelphia, PA, 07/2017-06/2020
  • Internal Medicine Residency Training, University of Maryland Medical Center, Baltimore, MD, 6/2014-06/2017
  • MD, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, 2014

Certifications

American Board of Internal Medicine

Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology

Honors & Awards

Awarded Honorable Mention for the Arnold R. Weitz, M.D. Memorial Prize in Hematology, 2014

Selected Publications

Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies. Nakhoda SK, Olszanski AJ. Pharmaceut Med. 2020 Apr;34(2):83-91. doi: 10.1007/s40290-020-00326-z. PMID: 32157638

Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Nakhoda S, Zimrin AB, Baer MR, Law JY. Transfus Apher Sci. 2017 Apr;56(2):123-126. doi: 10.1016/j.transci.2016.10.005. Epub 2016 Oct 17. PMID: 27789124 Clinical Trial.

Additional Publications

MyNCBI

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
​​
Resize Text

Related Articles